home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

226 rows where filing_period = "second_quarter", filing_year = 2013 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • MED · 226 ✖

filing_year 1

  • 2013 · 226 ✖

filing_period 1

  • second_quarter · 226 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1401276 PARRY, ROMANI, DECONCINI & SYMMS 22cf9f9b-6729-4ca8-8839-7b4d2c58d19f 2T PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2013 second_quarter MED Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE     0 1 2013-05-20T16:11:08.293000-04:00
1401280 PARRY, ROMANI, DECONCINI & SYMMS 62a95ebf-7a7c-45a2-83b0-2db37e871756 2T PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2013 second_quarter MED Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE     0 1 2013-05-20T16:20:10.977000-04:00
1401284 PARRY, ROMANI, DECONCINI & SYMMS 997802ff-308f-43af-8df5-bbef2d10ffc3 2T PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2013 second_quarter MED Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE     0 1 2013-05-20T16:34:13.347000-04:00
1401290 PARRY, ROMANI, DECONCINI & SYMMS 784014c6-1a40-482c-9cc6-cc890ab5188b 2T PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2013 second_quarter MED Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE     0 1 2013-05-20T16:45:15.340000-04:00
1401310 PARRY, ROMANI, DECONCINI & SYMMS 97180f1b-de8b-4e10-9e7c-456baf7320eb 2T PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2013 second_quarter MED Issues related to the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE     0 1 2013-05-20T17:05:18.880000-04:00
1401601 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 5aa2945d-ad75-49fa-b7dd-634dc5f9ddeb 2A AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 1375 AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 2013 second_quarter MED Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE     0 0 2013-06-05T14:06:36.930000-04:00
1401723 CHARLIE MCBRIDE ASSOCIATES 5b60f187-152a-4385-9dd8-8dc56a98d97c Q2 CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2013 second_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2013-06-19T09:52:05.830000-04:00
1401732 COLBY & COMPANY 1c90bb0c-d9b0-4b3d-9dbb-4fe9b8b0e251 Q2 COLBY & COMPANY 400394858 BIOOHIO 2013 second_quarter MED Urge repeal of medical device tax HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-06-19T15:12:06.920000-04:00
1401741 CHARLIE MCBRIDE ASSOCIATES 019c8cf5-aa8d-4a9d-b516-c68cd1256788 2A CHARLIE MCBRIDE ASSOCIATES 24214 BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA 2013 second_quarter MED To monitor legislation affecting medical energy research and technology-based economic development HOUSE OF REPRESENTATIVES,SENATE 7200   0 0 2013-06-20T10:55:23.440000-04:00
1401832 PALMETTO GROUP dee33fbc-d954-4181-98ab-2b436e71c264 Q2 PALMETTO GROUP 18570 INTERNATIONAL AIDS VACCINE INITIATIVE 2013 second_quarter MED Federal Funding of AIDS vaccine Department of State, Foreign Operations, and Related Programs Appropriations Act, 2014 SENATE 22500   0 0 2013-06-27T11:10:22.397000-04:00
1401953 MARSHALL BRACHMAN 0724a715-da5e-4aec-a4b1-60a6152e8400 Q2 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2013 second_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2013-07-01T00:31:34.430000-04:00
1402064 DALRYMPLE & ASSOCIATES, LLC 40e23c88-9060-4589-9914-9978074402f3 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) 2013 second_quarter MED Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 46000   0 0 2013-07-01T14:48:26.817000-04:00
1402072 DALRYMPLE & ASSOCIATES, LLC dad5fd86-1e44-4f5a-814f-4280b173ae97 Q2 DALRYMPLE & ASSOCIATES, LLC 5073 SANOFI PASTEUR 2013 second_quarter MED Vaccine research and development legislation, funding, appropriations and oversight. Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office 46000   0 0 2013-07-01T15:30:30.970000-04:00
1402297 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) c8718f45-8365-4fba-80ed-139390f0a5bc Q2 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 VIJUK EQUIPMENT, INC. 2013 second_quarter MED all matters dealing with pharmaceutical labeling Food & Drug Administration (FDA) 25000   0 0 2013-07-02T13:17:35.603000-04:00
1402381 ASSN OF MEDICAL DEVICE REPROCESSORS 23d0445c-8fca-4231-add5-a91ce0774bb5 Q2 ASSN OF MEDICAL DEVICE REPROCESSORS 291732 ASSN OF MEDICAL DEVICE REPROCESSORS 2013 second_quarter MED Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Contacted VA and House and Senate about regulations for reprocessed single-use medical devices. HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)     0 0 2013-07-02T14:51:16.777000-04:00
1402389 CORNERSTONE GOVERNMENT AFFAIRS, INC. 452ecc49-8bd4-45e7-b2c4-f7e120002f03 2T CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 PATH 2013 second_quarter MED Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2013-07-02T14:54:20.370000-04:00
1402454 AMERICAN COLLEGE OF CLINICAL PHARMACY 4670cda4-d6af-4311-b1bd-61e74dbf7a6a Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2013 second_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   111725 0 0 2013-07-02T16:07:53.320000-04:00
1402971 FRANCIS EDWARD & CRONIN, INC. 94424604-238f-4d75-a555-3838deaf0c7e Q2 FRANCIS EDWARD & CRONIN, INC. 311314 AMERICAN BRAIN TUMOR ASSOCIATION 2013 second_quarter MED Issues and legislation related to brain tumors and brain tumor research. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,White House Office 10000   0 0 2013-07-05T15:08:26.990000-04:00
1402973 FRANCIS EDWARD & CRONIN, INC. 1370b257-b431-4cea-b064-3c62b2d8503b Q2 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2013 second_quarter MED Legislation and issues related to Alzheimer's Disease Research Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office 10000   0 0 2013-07-05T15:14:28.890000-04:00
1403235 UNIVERSITY OF IOWA 8bb0490d-8531-450f-8557-c87606ae1355 Q2 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2013 second_quarter MED FY 2012 Appropriations Residency Caps Minority Improvement NIOSH Education and Research Centers for Occupational Health and SafetyPrevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations FY 2014 Appropriations Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   29312 0 0 2013-07-08T12:52:43.863000-04:00
1403809 FEDERAL SOLUTIONS, LLC abcae3ae-d48b-480e-8ef8-74d66e185031 Q2 FEDERAL SOLUTIONS, LLC 311371 JACKSONVILLE STATE UNIVERSITY 2013 second_quarter MED Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research, education, and development HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-07-09T16:01:34.570000-04:00
1403823 FEDERAL SOLUTIONS, LLC 24f00c8b-42df-4322-90a0-bfc3b47d6487 Q2 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2013 second_quarter MED Labor/HHS/Education Appropriations Bill 2013: Provisions relating to disease research Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2013-07-09T16:05:38.377000-04:00
1404046 THE CJR GROUP, INC. b103747f-330f-46da-a57d-5c8967aadc96 Q2 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2013 second_quarter MED Medical issues relating to hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-10T11:25:29.707000-04:00
1404277 WAKE FOREST UNIVERSITY HEALTH SCIENCES 4de74c96-248c-4210-bc95-7cd406dc1558 Q2 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2013 second_quarter MED NIH Budget including Title VII & VIII programs-Sequestration Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   145000 0 0 2013-07-10T14:23:46.640000-04:00
1404640 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. f5f2e7f7-6d54-429c-96a3-2e4607520f8b Q2 HARRISON RIVARD DUNCAN & BUZZETT, CHTD. 72257 HCA HEALTHCARE 2013 second_quarter MED Health and Medical Issues       0 0 2013-07-11T10:17:52.227000-04:00
1404796 LNE GROUP 837428c3-5f0d-4695-a826-5f04ac50761e Q2 LNE GROUP 308811 GOJO INDUSTRIES 2013 second_quarter MED Lobbied on issues regarding medical industry HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-11T11:55:07.697000-04:00
1404808 LNE GROUP 1a4919b1-8c69-4be0-b3f4-28eea72499a7 Q2 LNE GROUP 308811 OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) 2013 second_quarter MED Lobbied for issues within the medical field including reseach, and clinical labs HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-11T12:00:13.973000-04:00
1404909 LNE GROUP 4b7bafcc-e48a-4c33-81dc-14a23b2acfe7 Q2 LNE GROUP 308811 INTRINSIQ MATERIALS 2013 second_quarter MED Lobbied for issues regarding the medical research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-11T12:48:43.403000-04:00
1404965 LNE GROUP 7004c4d4-183c-42af-b6c7-e43cea4738fb Q2 LNE GROUP 308811 PARKER HANNIFIN 2013 second_quarter MED Lobbied on issues regarding the medical field/disease research/clinical labs HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2013-07-11T13:11:02.493000-04:00
1405005 LNE GROUP 3d83962d-9d8f-40ad-85c4-56e90bdd76dc Q2 LNE GROUP 308811 ZIMMER 2013 second_quarter MED Lobbied for medical device issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-11T13:30:13.010000-04:00
1405115 MASSACHUSETTS MEDICAL SOCIETY 0b38c9dc-2823-4137-9aa0-2e81237feec1 Q2 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2013 second_quarter MED Reclassification of marijuana so that its potential medicinal use by humans may be studied and potentially regulated by the FDA Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   60000 0 0 2013-07-11T14:58:10-04:00
1405134 MCDERMOTT WILL & SCHULTE LLP e5add7ca-188f-4919-863b-f9043eef2686 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 GENOMIC HEALTH INC 2013 second_quarter MED FDA regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-11T15:05:17.247000-04:00
1405226 PARRY, ROMANI, DECONCINI & SYMMS e81b1070-989b-4d91-8167-c9dcbed73d37 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AIDS HEALTHCARE FOUNDATION 2013 second_quarter MED Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014. Support funding for medical treatments for HIV positive patients. Support appropriate funding for the ADAP program. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-11T16:00:55.187000-04:00
1405702 GRIZZLE COMPANY 8f3968c1-3393-4162-9654-fde198e222a9 Q2 GRIZZLE COMPANY 16987 UNIVERSITY OF LOUISVILLE 2013 second_quarter MED Support for PICORI grant application. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2013-07-12T13:52:19.177000-04:00
1405729 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 576d254c-3cff-40b1-adce-2100df8785cb Q2 DEPARTMENT FOR PROFESSIONAL EMPLOYEES, AFL-CIO 12094 DEPARTMENT FOR PROFESSIONAL EMPLOYEES AFL-CIO 2013 second_quarter MED Strategies to Address Antimicrobial Resistance Act (H.R. 2285). Commerce, Dept of (DOC),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Endowment for the Arts,SENATE,U.S. International Trade Commission (ITC)   30000 0 0 2013-07-12T14:05:27.683000-04:00
1405967 MCDERMOTT WILL & SCHULTE LLP 59c68b6b-0506-4330-9d9d-f73943d12479 Q2 MCDERMOTT WILL & SCHULTE LLP 24338 COALITION FOR 21ST CENTURY MEDICINE 2013 second_quarter MED Issues concerning regulation of laboratory tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2013-07-12T15:57:38.157000-04:00
1406222 THE PETRIZZO GROUP, INC. 6e585274-f1bf-4f64-8229-84850b4590e0 Q2 THE PETRIZZO GROUP, INC. 305932 ALLEN INSTITUTE 2013 second_quarter MED Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. Support for full funding of NIH HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office 20000   0 0 2013-07-13T10:06:57.010000-04:00
1406229 BEN BARNES GROUP LP 10dfddcf-ed87-4467-a6ae-8df7a5404a05 Q2 BEN BARNES GROUP LP 5415 FAIR LABORATORY PRACTICES ASSOCIATION 2013 second_quarter MED Bring attention to prevention of unfair billing practices by laboratories for Medicare services HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-13T11:31:01.467000-04:00
1406251 BEN BARNES GROUP LP b8bc5ebe-8908-4f6a-be06-aec281cc06e2 Q2 BEN BARNES GROUP LP 5415 ROYALTY PHARMA - / RP MANAGEMENT, LLC 2013 second_quarter MED Tax Reform, Master Limited Partnership HOUSE OF REPRESENTATIVES,SENATE 150000   0 0 2013-07-13T13:38:15.930000-04:00
1406267 BEN BARNES GROUP LP 9de656e7-9fc3-4ce8-957a-9cabf730f2ba Q2 BEN BARNES GROUP LP 5415 TEXAS A&M SYSTEM 2013 second_quarter MED Assost the Texas A&M System in pursuit of various projects, general government relations HOUSE OF REPRESENTATIVES,SENATE 37500   0 0 2013-07-13T14:05:19.217000-04:00
1406336 THE PETRIZZO GROUP, INC. 9e205ce0-7f62-4028-a1e0-5e2c25a3dd81 Q2 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2013 second_quarter MED Advocate for federal funding for reaserch on traumatic brain injury, PTSD, and treatment of bleeding during surgery and trauma. Defense, Dept of (DOD) 30000   0 0 2013-07-14T12:12:09.070000-04:00
1406370 THE PETRIZZO GROUP, INC. 568f807a-8d43-4fe5-926d-6a322ed97e0f Q2 THE PETRIZZO GROUP, INC. 305932 FRED HUTCHINSON CANCER RESEARCH CENTER 2013 second_quarter MED Advocated for funding of the National Institutes of Health, and National Cancer Institute (NCI) for FY 2014 Funding. Advocated for collaboration between the federal government and the Institute for Cancer Outcomes Research and Evaluation to improve the efficiency and effectiveness of cancer prevention, early detection and treatment to reduce the economic and human burdens of cancer. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-14T16:40:27.997000-04:00
1406768 AMERICAN SOCIETY FOR MICROBIOLOGY 6e4c3883-716f-4ed1-a1eb-362a6b86ddc8 Q2 AMERICAN SOCIETY FOR MICROBIOLOGY 3355 AMERICAN SOCIETY FOR MICROBIOLOGY 2013 second_quarter MED Part B Clinical Laboratory Fee Schedule HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-15T13:13:33.107000-04:00
1407127 PERSONALIZED MEDICINE COALITION a7c8b2a7-df36-4d11-b375-7c1ff7b18d70 Q2 PERSONALIZED MEDICINE COALITION 40046362 PERSONALIZED MEDICINE COALITION 2013 second_quarter MED Personalized medicine regulation, CMS coverage of personalized medicine diagnostics, CER and Genomics, FDA regulation of personalized medicine Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2013-07-15T15:05:14.723000-04:00
1407186 AIR LIQUIDE USA LLC 97c7ebf1-d122-4b55-9597-94991360390e Q2 AIR LIQUIDE USA LLC 400596821 AIR LIQUIDE USA LLC 2013 second_quarter MED Regulatory and legislative matters related to medical gases and devices. Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE   136000 0 0 2013-07-15T15:19:39.333000-04:00
1407326 ROCK & ASSOCIATES ab512380-0599-4611-bb04-5888bafbbf95 Q2 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 9375   0 0 2013-07-15T16:04:39.283000-04:00
1407400 ROCK & ASSOCIATES eb9acebc-db43-492f-be6e-cbb9d4930a4a Q2 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 9375   0 0 2013-07-15T16:35:09.837000-04:00
1407419 ROCK & ASSOCIATES 7094df03-d02a-4234-962a-3ea487490c0f Q2 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-15T16:48:23.153000-04:00
1407462 ROCK & ASSOCIATES 498fa068-3053-4d32-ac5b-da816d24776b Q2 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 6750   0 0 2013-07-15T16:57:42.273000-04:00
1407501 ROCK & ASSOCIATES 1d8d2c2f-fa5e-420d-a3b4-822ebda287c5 Q2 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 9375   0 0 2013-07-15T17:12:02.090000-04:00
1407541 ROCK & ASSOCIATES b9b6673c-dc36-40e8-8941-fe4e67c331d7 Q2 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2013 second_quarter MED S.959, legislation affecting the operation of compounding pharmacies and the availability of compounded medications. HOUSE OF REPRESENTATIVES,SENATE 9375   0 0 2013-07-15T17:26:18.517000-04:00
1407612 THE OUTLAW GROUP 57e77e17-6700-4bce-893f-28180d590f3a Q2 THE OUTLAW GROUP 46095 AMERICAN TINNITUS ASSOCIATION 2013 second_quarter MED Legislation to ensure adequate funding of medical research on tinnitus. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-07-15T19:21:00.973000-04:00
1407669 GOLDBUG STRATEGIES LLC 5e71f954-82dc-48fe-8207-9bd56af00db5 Q2 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2013 second_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-16T09:30:26.097000-04:00
1407679 GOLDBUG STRATEGIES LLC ee90fa05-14c6-4694-ba36-50c61e19ddb2 Q2 GOLDBUG STRATEGIES LLC 400701094 LIFE TECHNOLOGIES/THERMO FISHER 2013 second_quarter MED regulation of medical devices, in vitro diagnostics and laboratory developed tests Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-16T09:37:28.887000-04:00
1407682 GOLDBUG STRATEGIES LLC e4955a74-bc65-42e4-bdb3-2e0d5f560d1c Q2 GOLDBUG STRATEGIES LLC 400701094 GENOMIC HEALTH INC. 2013 second_quarter MED FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-16T09:43:29.757000-04:00
1408018 WHITMER & WORRALL, LLC 66ba37cf-b1e9-416a-b425-bf7598df5c51 Q2 WHITMER & WORRALL, LLC 292892 NEURO KINETICS 2013 second_quarter MED Issues related to Traumatic Brain Injury (TBI). Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office 20000   0 0 2013-07-16T12:06:16.307000-04:00
1408560 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ba75dbde-082c-449b-86fb-13f5fec29400 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2013 second_quarter MED Research in hematology. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-07-16T15:10:14.347000-04:00
1408693 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 8709778b-e1eb-42fe-b195-140f3cab42f1 Q2 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 19822 INTERNATIONAL BROTHERHOOD OF ELECTRICAL WORKERS 2013 second_quarter MED The IBEW along with the AFL-CIO lobbied congress against changing the Medicare eligibility age and means testing of the Medicare program. Energy, Dept of,HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE   256319 0 0 2013-07-16T15:32:09.097000-04:00
1408764 WEBMD HEALTH CORP. 0c3d4d17-7909-4976-b980-c6b142632b47 Q2 WEBMD HEALTH CORP. 55473 WEBMD HEALTH CORP 2013 second_quarter MED Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal healthcare reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records SENATE   30000 0 0 2013-07-16T15:47:35.367000-04:00
1408794 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 318408bd-5de5-4cf1-ba50-6ab02e6fbf22 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 STATE UNIVERSITY SYSTEM OF FLORIDA 2013 second_quarter MED Appropriations and Authorization legislation for FY 2014 in health care HR 2397 Department of Defense Appropriations Bill 2014 and Senate bill HR 2216 Military Construction and Veterans Affairs Appropriations Bill FY2014 and Senate bill Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE 70000   0 0 2013-07-16T15:52:49.083000-04:00
1408865 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 847d1c4c-00e3-4677-89aa-e1bbf91400bd Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2013 second_quarter MED Hemophilia research, prevention, surveillance and service programs and issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2013-07-16T16:11:21.973000-04:00
1408896 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0707585d-0848-482f-9e83-ad0fc4286b99 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2013 second_quarter MED Research and public health programs in epilepsy. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2013-07-16T16:13:30.910000-04:00
1408919 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0d559b1f-b74b-460f-8345-925438756808 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION OF AMERICA'S BLOOD BANKS 2013 second_quarter MED Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-16T16:15:35.610000-04:00
1409233 FIRST STRATEGIC db35eb4f-8a79-42f4-9308-63fcfed3df6e 2T FIRST STRATEGIC 91091 PHOENIX CHILDREN'S HOSPITAL 2013 second_quarter MED Policies and legislation that may impact the hospital and its operations such as SCHIP/CHIPRA, 340b, children's graduate medical education (CHGME), disproportionate share hospital (DSH) funding, Medicaid and healthcare reform related provisions. Creation of the saftey net care pool through CMS. HOUSE OF REPRESENTATIVES,SENATE 30000   0 1 2013-07-16T19:31:28.347000-04:00
1409356 SRI INTERNATIONAL 0724a954-4e93-4def-8551-8d32d0080fce Q2 SRI INTERNATIONAL 90990 SRI INTERNATIONAL 2013 second_quarter MED House and Senate FY14 Labor/HHS/Education Appropriations HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2013-07-17T09:32:17.607000-04:00
1409392 BRET HEALY D/B/A RIVERBLUFF STRATEGIES 998f2091-fc1e-4108-924b-4aef5457bc77 2T BRET HEALY D/B/A RIVERBLUFF STRATEGIES 400581777 HEALTH EDUCATION RESOURCES AND OUTREACH, INC 2013 second_quarter MED Activities in support of a grant application to the Centers for Disease Control for a Type 2 diabetes education and outreach program. Health & Human Services, Dept of (HHS),SENATE 10000   0 1 2013-07-17T09:43:30.153000-04:00
1409525 POLICY DIRECTIONS INC. fda71a80-c9d5-406a-beef-65f0872a9994 Q2 POLICY DIRECTIONS INC. 31747 CHARLES RIVER LABORATORIES 2013 second_quarter MED Pre-clinical research models and drug discovery, development and testing. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-17T10:49:45.973000-04:00
1410240 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b5ba20d3-980b-4d17-990f-3806cfeb4f24 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 CRESCENDO BIOSCIENCE INC. 2013 second_quarter MED Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-17T14:46:43.630000-04:00
1410260 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7c7bf9cf-7457-4a88-8609-19a925c82f53 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ASSOCIATION FOR MOLECULAR PATHOLOGY 2013 second_quarter MED Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues. No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1309: Health Information Technology Reform Act HR 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013 Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE 30000   0 0 2013-07-17T14:50:50.813000-04:00
1410266 MEHLMAN CONSULTING, INC. d966f71d-9f80-4f18-afea-fd1a4be53075 Q2 MEHLMAN CONSULTING, INC. 284950 AMERICAN CLINICAL LABORATORY ASSOCIATION 2013 second_quarter MED Health reform law implementation issues including application of medical device tax to clinical laboratory tests and reform of laboratory fee schedule. In-office ancillary services exception to Stark Law. FDA oversight of laboratory-developed tests. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 80000   0 0 2013-07-17T14:52:54.263000-04:00
1410280 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a526a867-8403-4b60-bbd6-88cbbd0fe0c1 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 ONYX PHARMACEUTICALS 2013 second_quarter MED Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. Public Law No: 112-144 Food and Drug Administration Safety and Innovation Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2013-07-17T14:55:03.030000-04:00
1410310 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 766539f5-0ce2-4b1d-bac2-64e3799deff3 Q2 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 INTERNATIONAL MYELOMA FOUNDATION 2013 second_quarter MED Cancer Drug Coverage Parity Act, H.R. 1801 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-17T14:59:15.743000-04:00
1410958 INTERNATIONAL MYELOMA FOUNDATION 5a0fafa0-a55e-49de-9073-8ceb3955e3ed Q2 INTERNATIONAL MYELOMA FOUNDATION 400595820 INTERNATIONAL MYELOMA FOUNDATION 2013 second_quarter MED HR 1801, The Cancer Drug Coverage Parity Act HOUSE OF REPRESENTATIVES,SENATE   56000 0 0 2013-07-17T16:57:00.637000-04:00
1411036 UNIVERSITY OF ROCHESTER 5701a8e1-cbf1-4563-9f1d-49ffe857cc0e Q2 UNIVERSITY OF ROCHESTER 301937 UNIVERSITY OF ROCHESTER 2013 second_quarter MED Public Access S. 994, Digital Accountability and Transparency (DATA) Act HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2013-07-17T17:22:20.457000-04:00
1411129 THE CORMAC GROUP, LLC a61f4241-219b-423e-a2d4-ae22436463e2 Q2 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2013 second_quarter MED Appropriations, DOD, TBI research HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-17T18:02:07.930000-04:00
1411237 RAY C CULVER III 1fb7003e-2e23-4625-9633-91f4243e3e36 Q2 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2013 second_quarter MED Funding for the USDA ARS human nutrition centers in the FY14 Agricultural Appropriations bills, HR 2410 and S 1244. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-17T18:58:14.943000-04:00
1411979 THE PETRIZZO GROUP, INC. 8477f5f2-6306-46ca-b5f1-46df7e65c72b Q2 THE PETRIZZO GROUP, INC. 305932 VULCAN INC -- A PAUL G ALLEN COMPANY 2013 second_quarter MED Participated and advocated for the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative. HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2013-07-18T10:41:16.273000-04:00
1412456 AMERICAN ACADEMY OF FAMILY PHYSICIANS 0ab40c46-45b0-47a1-8b78-d117f38b3c81 Q2 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2013 second_quarter MED No Bill Number, ONDCP Drug Control Policy Plan Announcement, AAFP opposes CME mandates for opioid prescribing. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office   547922 0 0 2013-07-18T11:55:46.623000-04:00
1412631 THORN RUN PARTNERS 44fec034-b7ef-4d35-9ba3-672f64399c54 Q2 THORN RUN PARTNERS 400534596 ABBOTT LABORATORIES 2013 second_quarter MED Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition. HOUSE OF REPRESENTATIVES 40000   0 0 2013-07-18T12:23:49.757000-04:00
1412649 WASHINGTON UNIVERSITY IN ST. LOUIS 90d906a0-e7d9-42a7-bdea-3b216de63bab Q2 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2013 second_quarter MED General advocacy for NIH research, genomics research, and improved conflict of interest policies. HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2013-07-18T12:28:13.207000-04:00
1412684 O'NEILL AND ASSOCIATES 57106e4a-4b52-40ff-9ee6-8ee4dfc1ab9c Q2 O'NEILL AND ASSOCIATES 73134 THE JETT FOUNDATION 2013 second_quarter MED FDA Issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-07-18T12:39:10.387000-04:00
1412714 THORN RUN PARTNERS becc17b7-2f7c-48db-a9fc-0c5ec60deb8a Q2 THORN RUN PARTNERS 400534596 CHILDRENS HOSPITAL COLORADO 2013 second_quarter MED Issues related to clinical research. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-07-18T12:46:22.033000-04:00
1412915 ELI LILLY AND COMPANY b9e02363-d45d-489a-824c-41f27c0ac84f Q2 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2013 second_quarter MED NCATS Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1965000 0 0 2013-07-18T13:24:37.947000-04:00
1412942 THORN RUN PARTNERS b43be892-ad01-45b3-8134-8a65ba9c4e74 Q2 THORN RUN PARTNERS 400534596 NOVARTIS CORPORATION 2013 second_quarter MED Issues related to biologics. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-18T13:27:50.837000-04:00
1413327 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE e73b7a24-f010-48d9-9cdf-dca122c05c48 Q2 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 400382759 PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE 2013 second_quarter MED HR 1150-Preservation of Antibiotics for Medical Treatment Act of 2013. HOUSE OF REPRESENTATIVES,SENATE   25208 0 0 2013-07-18T14:44:34.603000-04:00
1414038 PRIME POLICY GROUP ce92342b-a155-42c8-b0e2-2e1b5649a56c Q2 PRIME POLICY GROUP 400532589 VERAX BIOMEDICAL, INC. 2013 second_quarter MED Blood Safety HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-18T16:04:55.477000-04:00
1414181 ALERE INC. ef640e08-5563-462b-8a3d-7ded2d061df4 Q2 ALERE INC. 400647952 ALERE INC. 2013 second_quarter MED Development of new and innovative in-vitro diagnostic tests. HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS)   159000 0 0 2013-07-18T16:20:48.043000-04:00
1414430 MEDEXPERT CONSULTING, INC. fb2d24d2-448b-4887-b6d9-7cc762fa891c Q2 MEDEXPERT CONSULTING, INC. 401061992 BIOCRYST PHARMACEUTICALS, INC. 2013 second_quarter MED Funding for development of medical countermeasures directed against bioterrorism agents that pose a significant threat to public health and national security. Defense Threat Reduction Agency (DTRA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-18T16:51:46.377000-04:00
1415321 GROUP HEALTH COOPERATIVE d6736593-ca19-4bb5-973e-16c1c047060a Q2 GROUP HEALTH COOPERATIVE 17022 GROUP HEALTH COOPERATIVE 2013 second_quarter MED Health systems and medical research topics. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Personnel Management (OPM),SENATE,White House Office   120000 0 0 2013-07-19T00:40:22.780000-04:00
1415329 W STRATEGIES, LLC 463c61de-7e46-4bcd-acb5-daaea107dfa7 Q2 W STRATEGIES, LLC 400605842 23ANDME, INC. 2013 second_quarter MED Issues relating to regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2013-07-19T01:45:27.840000-04:00
1415557 VAN SCOYOC ASSOCIATES 0933be56-e97e-4ecf-bbdd-4c98e9e1338b Q2 VAN SCOYOC ASSOCIATES 39837 STERILUCENT, INC. 2013 second_quarter MED H.R.5856, Department of Defense Appropriations Act, FY2013, Low temperature portable sterilization devices related issues. H.R.2397, Department of Defense Appropriations Act, FY2014, Low temperature portable sterilization devices related issues. Army, Dept of (Other),Navy, Dept of,U.S. Marines 20000   0 0 2013-07-19T07:50:41.620000-04:00
1415756 GEORGETOWN UNIVERSITY 17e0e29b-070f-4c39-9479-d7eb7bb7184b Q2 GEORGETOWN UNIVERSITY 62016 GEORGETOWN UNIVERSITY 2013 second_quarter MED Regulatory issues involved in domestic research on health benefits of probiotics in yogurt. Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE   20000 0 0 2013-07-19T09:27:38.013000-04:00
1416000 CROSSROADS STRATEGIES, LLC c6323b3a-d14d-4141-bd67-75f1f61043f0 Q2 CROSSROADS STRATEGIES, LLC 400531586 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2013 second_quarter MED S.644, PACT Act; issues related to preventing abuse or diversion of over-the-counter drugs; Food and Drug Administration Safety and Innovation Act, Public Law No: 112-144; issues related to insuring access to over-the-counter drugs. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2013-07-19T10:06:09.170000-04:00
1416020 AMERICAN ACADEMY OF PEDIATRICS 6d5e5a39-0a91-44c4-8548-bbec1d04482f Q2 AMERICAN ACADEMY OF PEDIATRICS 1397 AMERICAN ACADEMY OF PEDIATRICS 2013 second_quarter MED Medical Countermeasures for Children National Children's Study Inclusion of Children in Biomedical Research Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Education, Dept of,Environmental Protection Agency (EPA),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of,White House Office   112573 0 0 2013-07-19T10:09:18.200000-04:00
1416141 K&L GATES, LLP 759f3b97-3902-45c6-b5d8-a9f8aa70d788 Q2 K&L GATES, LLP 32098 SMITS SPEIDELL CONSULTING 2013 second_quarter MED Yet to be introduced: A bill to amend the Internal Revenue Code of 1986 to broaden the special rules for certain governmental plans under section 105(j) to include plans established by political subdivisions. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2013-07-19T10:27:00.433000-04:00
1416370 BAKER BOTTS, L.L.P. 870f5f39-7a77-4b4e-aa04-41ab1d7a16fe Q2 BAKER BOTTS, L.L.P. 5118 SOUTHERN METHODIST UNIVERSITY 2013 second_quarter MED Funding of neurophotonics research for prosthetic devices. HOUSE OF REPRESENTATIVES 50000   0 0 2013-07-19T10:56:38.350000-04:00
1416710 TURNER & GOSS LLP bf132d68-aa2f-49b1-848f-ef2ff57ec5e7 Q2 TURNER & GOSS LLP 316310 CANCER LEADERSHIP COUNCIL 2013 second_quarter MED S. 957, Drug Supply Chain Security Act H.R. 1919, Safeguarding America's Pharmaceuticals Act HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-19T11:28:55.557000-04:00
1417120 OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC acfd5c5d-13d9-4264-a9cd-d26acb1f57cd Q2 OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC 30212 ASSOCIATION OF MEDICAL DEVICE REPROCESSORS 2013 second_quarter MED Monitor and advocate on legislation regarding third party medical device reprocessing. HOUSE OF REPRESENTATIVES,SENATE     0 0 2013-07-19T12:02:27.720000-04:00
1417432 FAEGRE DRINKER BIDDLE & REATH LLP 87500f71-cc7a-4cc9-b6f4-c6fce7e80a38 Q2 FAEGRE DRINKER BIDDLE & REATH LLP 12631 HARM REDUCTION COALITION 2013 second_quarter MED Overdose Fatality Prevention Efforts Food & Drug Administration (FDA),SENATE 10000   0 0 2013-07-19T12:32:05.883000-04:00
1417503 FAEGRE DRINKER BIDDLE & REATH LLP bdbb9c1d-b4a4-4c36-b9d2-6f37e44069db 2T FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL PSORIASIS FOUNDATION 2013 second_quarter MED Psoriasis Data Collection. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2013-07-19T12:39:32.110000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1713.261ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API